Katia M. Verhamme, MD, MSc

Erasmus University Medical Center, Rotterdam, The Netherlands, Belgium

Poster(s):

• (179) Descriptive Analysis of Disproportionate Medication Errors and Associated Patient-Characteristics in The Food and Drug Administration's Adverse Event Reporting System
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST

• (C) The Impact of COVID-19 on Population-Level Drug Utilisation of Alendronate in Five European Databases
  Saturday, August 27, 2022

  8:00 AM – 6:00 PM CEST